The ubiquitin-proteasome pathway and resistance mechanisms developed against the proteasomal inhibitors in cancer cells.


Yerlikaya A. , Kanbur E.

Current drug targets, 2020 (SCI Expanded İndekslerine Giren Dergi) identifier